Michael Geschwind
Neurology · San Francisco, CANPI 1700813565
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $35,659 of the $45,850 with a category attached, or 77.8%. 8 manufacturers reported payments, led by Lilly USA, LLC at 48.6% of the total. Reporting peaked in 2024 at $22,321 and has fallen 89.7% since, to $2,300 in 2025. Among neurology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $2292.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$22K
- Microvention, Inc.$11K
- Genentech, Inc.$8K
- Regeneron$2K
- Biogen$2K
- Medtronic$264
- plus $242 from 2 others
Across 41 payments — averaging $10,524 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biohaven Pharmaceutical Holding Company Ltd.$213K
- Biohaven Pharmaceuticals, Inc.$194K
- Sage Therapeutics, LLC$22K
- Teva Pharmaceuticals USA, Inc.$3K
What the payments were for
- Consulting fees$35,65978%
- Travel & lodging$9,60921%
- Food & beverage$5811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 5 | $22,282 |
| Microvention, Inc. | 3 | $11,277 |
| Genentech, Inc. | 2 | $7,800 |
| Regeneron | 2 | $2,300 |
| Biogen | 2 | $1,684 |
| Medtronic(2 entities) | 2 | $264 |
| Teva Pharmaceuticals USA, Inc. | 3 | $151 |
| Genentech USA, Inc. | 1 | $91 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB$11,202
- PERCEPT PC BRAINSENSE$139
- ACTIVA$125
How this compares
$45,850 in reported general payments places this provider in the 90th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tetrabenazine | 12 | $36,629 |
Paid to pharmacies, not to this prescriber.
Other neurology in San Francisco
- S Claiborne JohnstonSan Francisco$576K
- Armen MoughamianSan Francisco$554K
- Scott ZamvilSan Francisco$447K
- Bruce CreeSan Francisco$412K
- Kenneth LaxerSan Francisco$379K
- Jonathan KatzSan Francisco$294K
- Nada HindiyehSan Francisco$268K
- Douglas GoodinSan Francisco$227K
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.